These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38740510)

  • 1. Endoscopic and histological risk stratification for gastric cancer using gastric intestinal metaplasia.
    Kawamura M; Uedo N; Yao K; Koike T; Kanesaka T; Hatta W; Ogata Y; Iwai W; Yokosawa S; Honda J; Asonuma S; Okata H; Ohyauchi M; Ito H; Abe Y; Ara N; Kayaba S; Shinkai H; Kanemitsu T
    J Gastroenterol Hepatol; 2024 May; ():. PubMed ID: 38740510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kyoto classification risk scoring system and endoscopic grading of gastric intestinal metaplasia for gastric cancer: Multicenter observation study in Japan.
    Kawamura M; Uedo N; Koike T; Kanesaka T; Hatta W; Ogata Y; Oikawa T; Iwai W; Yokosawa S; Honda J; Asonuma S; Okata H; Ohyauchi M; Ito H; Abe Y; Ara N; Kayaba S; Shinkai H; Shimokawa T
    Dig Endosc; 2022 Mar; 34(3):508-516. PubMed ID: 34415621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoscopic Grading of Gastric Intestinal Metaplasia Using Magnifying and Nonmagnifying Narrow-Band Imaging Endoscopy.
    Kawamura M; Koike T; Ogata Y; Matsumoto R; Yano K; Hiratsuka T; Ohyama H; Sato I; Kayada K; Suzuki S; Hiratsuka S; Watanabe Y
    Diagnostics (Basel); 2022 Dec; 12(12):. PubMed ID: 36553019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the endoscopic grading of gastric intestinal metaplasia in assessing gastric cancer risk: A systematic review and meta-analysis.
    Fang S; Fu Y; Du S; Wang L; Qing X; Luo X; Song G; Yang Y; Wei W
    Front Oncol; 2022; 12():1018248. PubMed ID: 36425561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linked color imaging-based endoscopic grading of gastric intestinal metaplasia and histological gastritis staging in the assessment of gastric cancer risk.
    Zheng J; Zhang G; Gao C; Xu G; Lin W; Jiang C; Li D; Wang W
    Scand J Gastroenterol; 2022 Nov; 57(11):1374-1380. PubMed ID: 35701150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric intestinal metaplasia assessment between linked color imaging based on endoscopy and pathology.
    Zhang G; Zheng J; Zheng L; Yu S; Jiang C; Lin W; Li D; Qu L; Wang W
    Scand J Gastroenterol; 2021 Jan; 56(1):103-110. PubMed ID: 33232631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoscopic grading of gastric intestinal metaplasia on risk assessment for early gastric neoplasia: can we replace histology assessment also in the West?
    Marcos P; Brito-Gonçalves G; Libânio D; Pita I; Castro R; Sá I; Dinis-Ribeiro M; Pimentel-Nunes P
    Gut; 2020 Oct; 69(10):1762-1768. PubMed ID: 32051208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbon footprint and cost reduction by endoscopic grading of gastric intestinal metaplasia using narrow-band imaging.
    Cho JH; Jin SY; Park S
    J Gastroenterol Hepatol; 2024 May; 39(5):942-948. PubMed ID: 38251795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pepsinogens to Distinguish Patients With Gastric Intestinal Metaplasia and Helicobacter pylori Infection Among Populations at Risk for Gastric Cancer.
    De Re V; Orzes E; Canzonieri V; Maiero S; Fornasarig M; Alessandrini L; Cervo S; Steffan A; Zanette G; Mazzon C; De Paoli P; Cannizzaro R
    Clin Transl Gastroenterol; 2016 Jul; 7(7):e183. PubMed ID: 27441820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoscopic grading of gastric intestinal metaplasia (EGGIM): a multicenter validation study.
    Esposito G; Pimentel-Nunes P; Angeletti S; Castro R; Libânio D; Galli G; Lahner E; Di Giulio E; Annibale B; Dinis-Ribeiro M
    Endoscopy; 2019 Jun; 51(6):515-521. PubMed ID: 30577062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reliability and accuracy of blue light imaging for staging of intestinal metaplasia in the stomach.
    Castro R; Rodriguez M; Libânio D; Esposito G; Pita I; Patita M; Santos C; Pimentel-Nunes P; Dinis-Ribeiro M
    Scand J Gastroenterol; 2019 Nov; 54(11):1301-1305. PubMed ID: 31680561
    [No Abstract]   [Full Text] [Related]  

  • 12. The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China.
    Wang X; Lu B; Meng L; Fan Y; Zhang S; Li M
    Scand J Gastroenterol; 2017 Aug; 52(8):822-827. PubMed ID: 28436254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Light blue crest and ridge/villous patterns in the uninvolved gastric antrum by magnifying NBI endoscopy correlate with serum pepsinogen and gastric cancer occurrence.
    Okubo M; Tahara T; Shibata T; Yonemura J; Yoshioka D; Kamiya Y; Nakamura M; Arisawaz T; Ohmiya N; Hirata I
    Hepatogastroenterology; 2014; 61(130):525-8. PubMed ID: 24901175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extending magnifying NBI diagnosis of intestinal metaplasia in the stomach: the white opaque substance marker.
    Kanemitsu T; Yao K; Nagahama T; Imamura K; Fujiwara S; Ueki T; Chuman K; Tanabe H; Atsuko O; Iwashita A; Shimokawa T; Uchita K; Kanesaka T
    Endoscopy; 2017 Jun; 49(6):529-535. PubMed ID: 28395383
    [No Abstract]   [Full Text] [Related]  

  • 15. A deep learning model based on magnifying endoscopy with narrow-band imaging to evaluate intestinal metaplasia grading and OLGIM staging: A multicenter study.
    Niu W; Liu L; Dong Z; Bu X; Yao F; Wang J; Wu X; Chen C; Mao T; Wu Y; Yuan L; Wan X; Zhou H
    Dig Liver Dis; 2024 Feb; ():. PubMed ID: 38402085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biopsy strategies for endoscopic screening of pre-malignant gastric lesions.
    Zhang M; Liu S; Hu Y; Bao HB; Meng LN; Wang XT; Xu Y; Zhao J; Lu B
    Sci Rep; 2019 Oct; 9(1):14909. PubMed ID: 31624309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoscopic diagnosis of gastric intestinal metaplasia in patients with autoimmune gastritis using narrow-band imaging: does pseudopyloric metaplasia muddy the waters?
    Dilaghi E; Esposito G; Pivetta G; Galli G; Pilozzi E; Annibale B; Lahner E
    Endosc Int Open; 2022 Apr; 10(4):E434-E440. PubMed ID: 35433221
    [No Abstract]   [Full Text] [Related]  

  • 18. A multicenter prospective study of the real-time use of narrow-band imaging in the diagnosis of premalignant gastric conditions and lesions.
    Pimentel-Nunes P; Libânio D; Lage J; Abrantes D; Coimbra M; Esposito G; Hormozdi D; Pepper M; Drasovean S; White JR; Dobru D; Buxbaum J; Ragunath K; Annibale B; Dinis-Ribeiro M
    Endoscopy; 2016 Aug; 48(8):723-30. PubMed ID: 27280384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histopathologically defined intestinal metaplasia in lesser curvature of corpus prior to Helicobacter pylori eradication is a risk factor for gastric cancer development.
    Hara D; Okamura T; Iwaya Y; Nagaya T; Ota H; Umemura T
    Helicobacter; 2022 Dec; 27(6):e12934. PubMed ID: 36263778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Narrow-band imaging with magnifying endoscopy is accurate for detecting gastric intestinal metaplasia.
    Savarino E; Corbo M; Dulbecco P; Gemignani L; Giambruno E; Mastracci L; Grillo F; Savarino V
    World J Gastroenterol; 2013 May; 19(17):2668-75. PubMed ID: 23674874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.